<?xml version="1.0" encoding="UTF-8"?>
<p>Severe disease determinants mediated by ADE are therefore multi-factorial and present a complex dynamic process. These include the natural decline of heterotypic neutralising antibodies but not homotypic neutralising antibodies over time [
 <xref rid="B64-vaccines-07-00203" ref-type="bibr">64</xref>]. Additionally, the presence of anti-prM antibodies, which may enable non-infectious immature DENV particles with uncleaved M protein (prM) to infect host cells [
 <xref rid="B65-vaccines-07-00203" ref-type="bibr">65</xref>,
 <xref rid="B87-vaccines-07-00203" ref-type="bibr">87</xref>,
 <xref rid="B88-vaccines-07-00203" ref-type="bibr">88</xref>]. DENV particles are also extremely dynamic, undergoing a process known as viral ‘breathing’ which can also affect the ability of neutralising antibodies to bind [
 <xref rid="B4-vaccines-07-00203" ref-type="bibr">4</xref>,
 <xref rid="B15-vaccines-07-00203" ref-type="bibr">15</xref>].
</p>
